Interleukin-18 and diabetic nephropathy: A review

被引：94
|
作者：
Yaribeygi, Habib [1 ]
Atkin, Stephen L. [2 ]
Sahebkar, Amirhossein [3 ,4 ,5 ]
机构：
[1] Shahid Beheshti Univ Med Sci, Chron Kidney Dis Res Ctr, Tehran, Iran
[2] Weill Cornell Med Qatar, Doha, Qatar
[3] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Iran
[4] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Iran
[5] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Iran
来源：
JOURNAL OF CELLULAR PHYSIOLOGY | 2019年 / 234卷 / 05期
关键词：
apoptosis; diabetic nephropathy; inflammatory response; interleukin-18; oxidative stress; tumor necrosis factor-alpha; NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; INTERCELLULAR-ADHESION MOLECULE-1; ISOLATED RAT GLOMERULI; TNF-ALPHA PRODUCTION; GROWTH-FACTOR-BETA; IFN-GAMMA; FAS LIGAND; TGF-BETA; SIGNAL-TRANSDUCTION;
D O I：
10.1002/jcp.27427
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
The inflammatory response has an important role in the pathophysiology of diabetic nephropathy that is contributed to by inflammatory mediators such as interleukin-1 (IL-1), IL-6, IL-18, tumor necrosis factor-alpha, and macrophage chemotactic protein-1; however, the role of IL-18 seems to be more specific than other cytokines in the inflammatory process. IL-18 is expressed in renal tissue and is upregulated by several stimuli including hyperglycemia. The expression/urinary level of IL-18 is positively correlated with the progression of diabetic nephropathy and the urinary albumin excretion rate. In this review, we have focused on the molecular pathways modulating the relationship between IL-18 and diabetic nephropathy.
引用
收藏
页码：5674 / 5682
页数：9
相关论文
共 50 条
  • [1] Association of interleukin-18 polymorphisms and the susceptibility to diabetic nephropathy
    Bai, Liwei
    Wang, Di
    Zhai, Qianqian
    Wang, Jianling
    Hai, Jie
    Jin, Sumei
    Zhang, Qinggui
    Wang, Tao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (10): : 10522 - 10528
  • [2] Interleukin-18 contributes more closely to the progression of diabetic nephropathy than other diabetic complications
    Fujita, Takayuki
    Ogihara, Norikazu
    Kamura, Yumi
    Satomura, Atsushi
    Fuke, Yoshinobu
    Shimizu, Chie
    Wada, Yuki
    Matsumoto, Koichi
    ACTA DIABETOLOGICA, 2012, 49 (02) : 111 - 117
  • [3] Interleukin-18 contributes more closely to the progression of diabetic nephropathy than other diabetic complications
    Takayuki Fujita
    Norikazu Ogihara
    Yumi Kamura
    Atsushi Satomura
    Yoshinobu Fuke
    Chie Shimizu
    Yuki Wada
    Koichi Matsumoto
    Acta Diabetologica, 2012, 49 : 111 - 117
  • [4] Elevated serum levels of interleukin-18 in patients with overt diabetic nephropathy: effects of miglitol
    Takashi Uzu
    Hiroki Yokoyama
    Hirofumi Itoh
    Daisuke Koya
    Atsushi Nakagawa
    Makoto Nishizawa
    Hiroshi Maegawa
    Yukiyo Yokomaku
    Shin-ichi Araki
    Atsuko Abiko
    Masakazu Haneda
    Clinical and Experimental Nephrology, 2011, 15 : 58 - 63
  • [5] Association of interleukin-18 promoter polymorphism and atherosclerotic diseases in Chinese patients with diabetic nephropathy
    Szeto, Cheuk-Chun
    Chow, Kai-Ming
    Poon, Peter Yam-Kau
    Kwan, Bonnie Ching-Ha
    Li, Philip Kam-Tao
    NEPHROLOGY, 2009, 14 (06) : 606 - 612
  • [6] Elevated serum levels of interleukin-18 in patients with overt diabetic nephropathy: effects of miglitol
    Uzu, Takashi
    Yokoyama, Hiroki
    Itoh, Hirofumi
    Koya, Daisuke
    Nakagawa, Atsushi
    Nishizawa, Makoto
    Maegawa, Hiroshi
    Yokomaku, Yukiyo
    Araki, Shin-ichi
    Abiko, Atsuko
    Haneda, Masakazu
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2011, 15 (01) : 58 - 63
  • [7] Increased serum interleukin-18 concentrations in type 2 diabetic subjects with and without nephropathy
    Moriwaki, Y
    Takahashi, S
    Tsutsumi, Z
    Ka, T
    Inokuchi, T
    Yamamoto, T
    PROCEEDINGS OF THE 12TH INTERNATIONAL CONGRESS OF ENDOCRINOLOGY, 2004, : 607 - 610
  • [8] Imbalance of Interleukin-18 and Interleukin-18 Binding Protein in Patients with IgA Nephropathy Implicating Renal Vasculopathy
    Shimizu, Chie
    Matsumoto, Koichi
    Fujita, Takayuki
    Fuke, Yoshinobu
    Soma, Masayoshi
    CLINICAL LABORATORY, 2015, 61 (1-2) : 23 - 30
  • [9] Interleukin-18 binding protein therapy is protective in adriamycin nephropathy
    Wyburn, Kate R.
    Chadban, Steven J.
    Kwan, Tony
    Alexander, Stephen I.
    Wu, Huiling
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2013, 304 (01) : F68 - F76
  • [10] Serum interleukin-18 binding protein increases with behavior different from IL-18 in patients with diabetic nephropathy
    Fujita, Takayuki
    Shimizu, Chie
    Fuke, Yoshinobu
    Satomura, Atsushi
    Abe, Masanori
    Kaizu, Kazo
    Matsumoto, Koichi
    Soma, Masayoshi
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 92 (03) : E66 - E69
12345